Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
262.41
+1.40 (+0.54%)
Streaming Delayed Price
Updated: 9:59 AM EDT, Oct 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Should You Still Buy the Dow Jones' Best-Performing September Stocks?
Today 5:10 EDT
A handful of blue-chip tickers defied the bigger bearish tide last month, but that doesn't necessarily make these stocks a buy.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Is Amgen's Lung Cancer Drug Lumakras Up to the Mark? FDA Briefing Raises Concerns
October 03, 2023
The FDA released briefing documents ahead of Oncologic Drugs Advisory Committee meeting scheduled for October 5 to review Amgen Inc's (NASDAQ:
Via
Benzinga
Exposures
Product Safety
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration
Via
Benzinga
Check Out What Whales Are Doing With AMGN
September 29, 2023
Via
Benzinga
AskSlim Market Week - Friday, Sep. 29
September 29, 2023
Technical and cycle analysis, and market commentary.
Via
Talk Markets
2 Dividend Growth Stocks to Buy Right Now
September 21, 2023
A wise man once said, be greedy when others are fearful.
Via
The Motley Fool
Check Out What Whales Are Doing With AMGN
September 20, 2023
Via
Benzinga
Amgen Unusual Options Activity
September 15, 2023
Via
Benzinga
3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals
September 28, 2023
The demand for biotech stocks is intense and is likely to only greatly increase going forward, especially in the United States.
Via
InvestorPlace
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average
September 27, 2023
The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients
September 25, 2023
The FDA issued a Complete Response Letter regarding the Biologics License Application supplement for Udenyca Onbody, Coherus BioSciences Inc's (NASDAQ: CHRS) on-body injector (OBI) presentation of...
Via
Benzinga
Exposures
Product Safety
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today
September 13, 2023
Via
Benzinga
2 Top Dividend Stocks to Buy in September
September 13, 2023
These two blue-chip dividend stocks have stood the test of time.
Via
The Motley Fool
How Is The Market Feeling About Amgen?
September 08, 2023
Via
Benzinga
8 Analysts Have This to Say About Amgen
September 05, 2023
Via
Benzinga
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
September 22, 2023
Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Shares of Neumora Therapeutics Slumped This Week
September 21, 2023
The clinical-stage biotech just had its IPO last week.
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
3 Quality Dividend Stocks For A Bear Market
September 14, 2023
The potential for a recession means investors should focus on quality dividend stocks with strong yields.
Via
Talk Markets
Topics
Economy
Exposures
Economy
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
September 13, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
September 12, 2023
While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.
Via
InvestorPlace
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has
Via
Benzinga
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However,...
Via
Benzinga
Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations
September 05, 2023
On Friday, the U.S.
Via
Benzinga
Should You Still Buy the Dow Jones' Best-Performing August Stocks?
September 05, 2023
They're rolling now, but this market has been too hot-and-cold of late to ignore any company's -- or company's stock's -- underlying bigger picture.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
The 3 Most Promising Dow Stocks to Own Now
September 03, 2023
The Dow market leaders got their heads handed to them in August. Here are three must-own Dow stocks to own for the long haul.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?
Via
The Motley Fool
Stock Market Rally Gains Momentum As Treasury Yields Slide; Tesla Unveils Model 3 Upgrade: Weekly Review
September 01, 2023
Tesla unveiled an updated Model 3, but also slashed Model S, X prices.
Via
Investor's Business Daily
Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal
September 01, 2023
The U.S. Federal Trade Commission (FTC) has approved drug manufacturer Amgen Inc (NASDAQ: AMGN) to proceed with its $27.8 billion acquisition of Horizon Therapeutics Plc (NASDAQ: HZNP).
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.